The activity of the DAF-2 insulin/IGFI receptor homolog is required for non-dauer development and normal adult life span, and is likely to be regulated by one or more insulin-like ligands. A comprehensive search of the C. elegans genome identified 37 ins genes predicted to encode insulin-like peptides.
ins-1 on F13B12 is most closely related to mammalian insulins, based on structural predictions and likely C-peptide cleavage sites typical of mammalian insulins. To test whether the ins genes could play a role in dauer formation, several were overexpressed by injecting worms with the appropriate PCR-amplified genomic regions. We hypothesized that overexpression of putative DAF-2 ligands might suppress the Daf-c phenotype of weak
daf-2 mutants. None of the tested genes suppressed
daf-2(
e1365) at 26C. Unexpectedly, the
ins-1, but not the
ins-9,
ins-22 or
ins-19/31, transgene strongly enhanced
daf-2(
e1365) and
daf-2(
e1370)at 20C. Reducing the injected
ins-1 DNA by 10-fold decreased the enhancement but never caused suppression of
daf-2(
e1365), suggesting an endogenous role for INS-1 as a DAF-2 antagonist rather than saturation of DAF-2 to a non-signaling state by excess INS-1. The
ins-1 transgene also enhanced a mutation in
daf-7, which encodes the ligand for a parallel TGF- pathway that synergizes with the
daf-2 insulin-like signaling pathway. An
ins-1 transgene in which the coding region was replaced with the human insulin cDNA had similar effects. Like many other ins genes, an
ins-1::GFP transgene is expressed in many neurons, as well as intestine, and vulval muscles. Lastly, a deletion mutant,
ins-1(
nr2091), lacking the entire coding region, did not enhance or suppress dauer formation in wild type,
daf-2, or
daf-7 backgrounds. Thus, although overexpression of
ins-1 can enhance dauer arrest in these backgrounds,
ins-1 is not required for dauer arrest. Other ins genes may act redundantly as agonists or as antagonists of DAF-2.